Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTexas Woman's University
About this trial
The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Individuals 18 years and older
diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms.
age (+/- one year) and gender matched individuals
no diagnosed peripheral neuropathy
Disqualifiers
Unable to follow two step commands.
Unable to ambulate x 50 feet independently without use of an assistive device.
Unable to use a phone to send text messages.
Diagnosis of diabetic peripheral neuropathy
Trial population
Non CNS Cancer population with neuropathy symptoms related to cancer treatments.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
40 Participants
are grouped into 2 trial groupsGroup A: Cancer treatment induced peripheral neuropathy
Group B: Control group
Trial outcomes
Primary outcomes
1
Fall risk
Fall risk will be assessed using the Timed Up and Go (TUG)-Test. For the TUG, the participant will be asked to stand up from a chair, walk 3 m and touch a line on the floor, walk back to the chair and sit down. Timing of the test will begin when the tester gives the command "go" and will be stopped when the participant made contact with the chair as they sat down.
Time frame
5 minutes2
Quality of life- in cancer patients
Participants in the cancer related peripheral neuropathy group will complete the Functional Assessment of Cancer Therapy- General (FACT-G ) to assess self-reported quality of life. The FACT-G uses a 5-point Likert scale, with higher numbers indicating a better health state.
Time frame
5 minutesSecondary outcomes
1
Trail Making Test (TMT) Parts A & B
Trail Making Test assesses attention, psychomotor, and higher-level cognitive function and has been recommended to be used to in cancer population. The time it takes to complete the parts A and B will be recorded in seconds
Time frame
5 minutes2
Single Task- Working Memory
Single task assessment of working memory will be assessed by randomly picking one of the following tests (serial sevens (7s), spelling words backwards or recite months backwards) for 30 seconds in seated position.
Time frame
3 minutes3
Single Task- Visual Attention Cognitive Task
Visual-attention cognitive tasks will be tested by randomly selecting one of the following texting activity for 30 seconds (texting animal names, cities, or colors on a smart phone) in a seated position.
Time frame
3 minutes4
Protective Sensation
Protective sensation in the upper and lower extremities will be measured using the Semmes-Weinstein monofilament.
Time frame
5 minutesSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov